These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2668074)

  • 41. Microarray-based gene expression analysis as a process characterization tool to establish comparability of complex biological products: scale-up of a whole-cell immunotherapy product.
    Wang M; Senger RS; Paredes C; Banik GG; Lin A; Papoutsakis ET
    Biotechnol Bioeng; 2009 Nov; 104(4):796-808. PubMed ID: 19591186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A survey of primary lung cancer among NTT workers in the Tokyo area. The incidence and mortality during the past 30 years and significance of radiologic screening].
    Miyagawa H; Yamada R; Tamura S
    Sangyo Igaku; 1993 Sep; 35(5):395-402. PubMed ID: 8230800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Human embryonic stem cells. Problems and perspectives].
    Nikol'skiĭ NN; Gibaĭ IA; Somova NV
    Tsitologiia; 2007; 49(7):529-37. PubMed ID: 17918336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are continuous cell lines safe as substrates for human drugs and biologics? A case study with human growth hormone.
    Carter MJ; Facklam TJ; Long PC; Scotland RA
    Dev Biol Stand; 1989; 70():101-7. PubMed ID: 2759344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WHO Expert Committee On Biological Standardization.
    World Health Organ Tech Rep Ser; 1998; 878():i-vi, 1-101. PubMed ID: 9731464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should continuous cell lines be used as substrates for biological products?
    Petricciani JC
    Dev Biol Stand; 1987; 66():3-12. PubMed ID: 3582759
    [No Abstract]   [Full Text] [Related]  

  • 50. WHO Expert Committee on biological standardization.
    World Health Organ Tech Rep Ser; 2007; (941):1-340, back cover. PubMed ID: 18314862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regulatory science forum--its background and goal].
    Uchiyama M
    Eisei Shikenjo Hokoku; 1993; (111):140-1. PubMed ID: 7920557
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The birth of therapy with cultured cells.
    Green H
    Bioessays; 2008 Sep; 30(9):897-903. PubMed ID: 18693268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A set of stage-dependent embryonic antigens expressed in cell cultures of BALB/c mouse embryos and in transformed cell lines.
    Gerhards RE; Mehnert FE
    J Cell Biochem; 1986; 31(1):27-39. PubMed ID: 3013908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. World Health Organization attitude concerning the use of continuous cell lines as substrates for production of human virus vaccines.
    Grachev VP
    Adv Biotechnol Processes; 1990; 14():37-67. PubMed ID: 2222837
    [No Abstract]   [Full Text] [Related]  

  • 55. WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.
    Knezevic I; Stacey G; Petricciani J;
    Biologicals; 2008 May; 36(3):203-11. PubMed ID: 18218325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesosomes and scientific methodology.
    Hudson RG
    Hist Philos Life Sci; 2003; 25(2):167-91. PubMed ID: 15295865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Statistical analysis of the age-adjusted incidence rates of human neoplasias: changes in time and space from early 1960's to mid 1980's with special reference to the steroid criminal hypothesis of carcinogenesis.
    Kodama M; Murakami M; Kodama T
    Int J Mol Med; 1999 Apr; 3(4):435-41. PubMed ID: 10085420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of cell substrates used for human biologicals: An overview of international regulatory documents.
    Zaninelli P; Barone D
    Toxicol In Vitro; 1990; 4(4-5):720-1. PubMed ID: 20702265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. International Science Gains Higher Profile: Both Administration and Congress look for ways to deal with new set of problems that have emerged in the 1980's.
    Walsh J
    Science; 1986 Mar; 231(4743):1240-1. PubMed ID: 17839553
    [No Abstract]   [Full Text] [Related]  

  • 60. Arms Control: Modest But Neutral Record: Agreements reached in the 1960's and 1970's have had limited impact but have not harmed U.S. interests.
    Norman C
    Science; 1986 Nov; 234(4780):1065. PubMed ID: 17778935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.